BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31181432)

  • 1. Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy.
    Ghourchian S; Mousavi A; Zamani B; Shahidi G; Rohani M
    Clin Neurol Neurosurg; 2019 Aug; 183():105383. PubMed ID: 31181432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
    Morelli M; Arabia G; Messina D; Vescio B; Salsone M; Chiriaco C; Perrotta P; Rocca F; Cascini GL; Barbagallo G; Nigro S; Quattrone A
    Mov Disord; 2014 Apr; 29(4):488-95. PubMed ID: 24573655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
    Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
    Taniguchi D; Hatano T; Kamagata K; Okuzumi A; Oji Y; Mori A; Hori M; Aoki S; Hattori N
    Mov Disord; 2018 Sep; 33(9):1488-1492. PubMed ID: 29756366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior cerebellar peduncle atrophy of progressive supranuclear palsy on phase difference enhanced imaging: a comparison with Parkinson's disease.
    Miyata M; Kakeda S; Yoneda T; Ide S; Okada K; Adachi H; Korogi Y
    Neuroradiology; 2023 Apr; 65(4):719-727. PubMed ID: 36670276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesencephalic area measured by transcranial sonography in the differential diagnosis of parkinsonism.
    Sastre-Bataller I; Vázquez JF; Martínez-Torres I; Sahuquillo P; Rubio-Agustí I; Burguera JA; Ferrer JM; Valero C; Tembl JI
    Parkinsonism Relat Disord; 2013 Aug; 19(8):732-6. PubMed ID: 23684370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating progressive supranuclear palsy from other movement disorders using transcranial sonography: a systematic review and meta-analysis.
    Wen Y; Zhou H; Xia M; Liu Q; Quan H; Fang L
    Neurol Sci; 2024 Feb; 45(2):455-465. PubMed ID: 37819487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
    Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
    Luca A; Nicoletti A; Donzuso G; Terravecchia C; Cicero CE; D'Agate C; Rascuná C; Manna R; Mostile G; Zappia M
    J Alzheimers Dis; 2021; 80(4):1669-1674. PubMed ID: 33720901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
    Azuma M; Hirai T; Nakaura T; Kitajima M; Yamashita S; Hashimoto M; Yamada K; Uetani H; Yamashita Y; Wang Y
    J Neurol Sci; 2019 Nov; 406():116443. PubMed ID: 31634718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
    Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomographic findings of progressive supranuclear palsy compared with Parkinson's disease.
    Yuki N; Sato S; Yuasa T; Ito J; Miyatake T
    Jpn J Med; 1990; 29(5):506-11. PubMed ID: 2089174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.